Analysis of the glyco-code in pancreatic ductal adenocarcinoma identifies glycan-mediated immune regulatory circuits

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most aggressive malignancies with a 5-year survival rate of only 9%. Despite the fact that changes in glycosylation patterns during tumour progression have been reported, no systematic approach has been conducted to evaluate its potential fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodriguez, Ernesto, Boelaars, Kelly, Brown, Kari, Madunić, Katarina, van Ee, Thomas, Dijk, Frederike, Verheij, Joanne, Li, R. J. Eveline, Schetters, Sjoerd T. T., Meijer, Laura L., Le Large, Tessa Y. S., Driehuis, Else, Clevers, Hans, Bruijns, Sven C. M., O’Toole, Tom, van Vliet, Sandra J., Bijlsma, Maarten F., Wuhrer, Manfred, Kazemier, Geert, Giovannetti, Elisa, Garcia-Vallejo, Juan J., van Kooyk, Yvette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752754/
https://www.ncbi.nlm.nih.gov/pubmed/35017635
http://dx.doi.org/10.1038/s42003-021-02934-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752754/
https://www.ncbi.nlm.nih.gov/pubmed/35017635
http://dx.doi.org/10.1038/s42003-021-02934-0

Ejemplares similares